Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 31, 2018
Effects of BDNF Val<sup>66</sup>Met genotype and schizophrenia familial risk on a neural functional network for cognitive control in humansJ I Schweiger, E Bilek, A Schäfer, et al.
Translational Psychiatry|January 11, 2017
Functional neuroimaging effects of recently discovered genetic risk loci for schizophrenia and polygenic risk profile in five RDoC subdomainsS Erk, S Mohnke, S Ripke, et al.
Molecular Psychiatry|January 30, 2013
Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia lociA D Børglum, D Demontis, J Grove, et al.
Genes, Brain, and Behavior|July 1, 2014
GWAS-based pathway analysis differentiates between fluid and crystallized intelligenceA Christoforou, T Espeseth, G Davies, et al.
Molecular Psychiatry|September 2, 2015
High loading of polygenic risk in cases with chronic schizophreniaS M Meier, E Agerbo, R Maier, et al.
Translational Psychiatry|July 8, 2015
Duplications in RB1CC1 are associated with schizophrenia; identification in large European sample setsF Degenhardt, L Priebe, S Meier, et al.
Molecular Psychiatry|April 1, 2015
Whole-genome association analysis of treatment response in obsessive-compulsive disorderH Qin, J F Samuels, Y Wang, et al.
Molecular Psychiatry|May 14, 2014
Genome-wide association study in obsessive-compulsive disorder: results from the OCGASM Mattheisen, J F Samuels, Y Wang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 24, 2017
Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCDW Guo, J F Samuels, Y Wang, et al.
Molecular Psychiatry|August 21, 2013
Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility geneX-J Luo, M Li, L Huang, et al.
Pageof 4